Viewing Study NCT04347967


Ignite Creation Date: 2025-12-25 @ 12:39 AM
Ignite Modification Date: 2026-05-22 @ 12:06 AM
Study NCT ID: NCT04347967
Status: UNKNOWN
Last Update Posted: 2023-12-04
First Post: 2020-04-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Mesenchymal Stem Cells for The Treatment of Acute Respiratory Distress Syndrome (ARDS)
Sponsor: Meridigen Biotech Co., Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Respiratory Distress Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ARDS View